News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Labopharm: Supplier’s Manufacturing Unit Cleared by FDA
October 7, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Labopharm Inc's supplier Angelini, which makes the active pharmaceutical ingredient (API) for the company's antidepressant trazodone, has resolved outstanding manufacturing issues with the U.S. Food and Drug Administration.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Insights
Labs see rising demand for nitrosamine, topical performance and microbiome testing
June 25, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Duchenne muscular dystrophy
REGENXBIO bets on FDA flexibility with filing plans for Duchenne gene therapy
June 24, 2026
·
2 min read
·
Gabrielle Masson
FDA
BIO CEO Crowley, DOD doctor Overton are top candidates for FDA commissioner: RBC
June 24, 2026
·
3 min read
·
Heather McKenzie
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
·
1 min read
·
Jef Akst